Table 1.
Anthropometric and biochemical clinical characteristics of the studied cohort. Data are expressed as mean ± standard deviation (SD) before and 4 weeks after the intervention.
| ALL (N = 40) | Before | After | p-Value * | |
|---|---|---|---|---|
| Age (years) | 52.55 ± 5.06 | - | - | |
| Weight (kg) | 133.38 ± 21.39 | 126.24 ± 19.17 | Ns | |
| BMI (Kg/m2) | 44.45 ± 6.54 | 42.04 ± 5.83 | Ns | |
| Waist (cm) | 133.28 ± 12.47 | 125.55 ± 10.99 | 0.005 | |
| Sys P (mmHg) | 147.31 ± 18.53 | 124.62 ± 11.40 | <0.0001 | |
| Diast P (mmHg) | 87.44 ± 8.69 | 79.36 ± 8.18 | <0.0001 | |
| Heart Rate (bpm) | 80.74 ± 10.71 | 75.79 ± 10.62 | 0.05 | |
| FM (kg) | 56.71 ± 14.23 | 52.70 ± 13.62 | Ns | |
| FM (%) | 42.31 ± 4.41 | 41.07 ± 4.98 | Ns | |
| FFM (kg) | 75.61 ± 11.02 | 74.38 ± 9.59 | Ns | |
| FFM (%) | 57.57 ± 4.51 | 58.94 ± 4.98 | Ns | |
| MM (kg) | 40.89 ± 5.99 | 40.04 ± 4.64 | Ns | |
| MM (%) | 31.24 ± 4.52 | 32.00 ± 4.49 | Ns | |
| REE (Kcal/die) | 2105.64 ± 257.73 | 2022.44 ± 256.45 | Ns | |
| Glucose (mg/dL) | 97.70 ± 10.18 | 91.03 ± 8.01 | 0.002 | |
| Insulin (mU/L) | 18.79 ± 5.91 | 17.36 ± 6.96 | Ns | |
| HbA1c (%) | 5.79 ± 0.39 | 5.53 ± 0.48 | 0.01 | |
| HDL (mg/dL) | 38.65 ± 6.72 | 35.30 ± 6.05 | 0.023 | |
| LDL (mg/dL) | 132.28 ± 36.39 | 113.40 ± 29.98 | 0.01 | |
| TG (mg/dL) | 159.80 ± 42.42 | 134.33 ± 37.63 | 0.006 | |
| 6MWT (meters) | 477.06 ± 132.66 | 531.00 ± 81.68 | 0.04 | |
| HGS (right arm) | 44.70 ± 9.14 | 46.41 ± 9.77 | Ns | |
| HGS (left arm) | 41.76 ± 8.50 | 43.42 ± 9.23 | Ns | |
Abbreviations: BMI: Body Mass Index; Sys P: Systolic Blood pressure; Diast P: Diastolic Blood Pressure; FM: Fat Mass; FFM: Fat-free Mass; MM: Muscular Mass; REE: Resting Energy expenditure; HbA1c: Glycated hemoglobin; HDL: high-density lipoproteins; LDL: low-density lipoproteins; TG: triglycerides; 6MWT: 6-min walking test; HGS: Handgrip Strength. * Wilcoxon signed-rank test.